Cargando…
CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer
Purpose: Esophageal cancer (ESCA) progression and chemoresistance are critical factors that impact the survival of patients with esophageal cancer. Cyclin dependent kinase inhibitor 3 (CDKN3) is an important regulator of the cell cycle that has received little attention, therefore the purpose of thi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489875/ https://www.ncbi.nlm.nih.gov/pubmed/31114363 http://dx.doi.org/10.2147/CMAR.S193793 |